OCM
GILD icon

Oakwood Capital Management’s Gilead Sciences GILD Stock Holding History

Oakwood Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-47,673
Closed -$3.02M – 48
2019
Q3 		$3.02M Sell
47,673
-930
-2% -$60.8K 1.34% 34
2019
Q2 		$3.28M Sell
48,603
-520
-1% -$34.2K 1.41% 32
2019
Q1 		$3.19M Sell
49,123
-550
-1% -$36.6K 1.34% 35
2018
Q4 		$3.11M Buy
49,673
+235
+0.5% +$16.4K 1.46% 31
2018
Q3 		$3.82M Buy
49,438
+285
+0.6% +$21.5K 1.55% 32
2018
Q2 		$3.48M Sell
49,153
-605
-1% -$42.7K 1.47% 34
2018
Q1 		$3.75M Buy
49,758
+9,928
+25% +$789K 1.6% 34
2017
Q4 		$2.85M Sell
39,830
-10,485
-21% -$796K 0.63% 54
2017
Q3 		$4.08M Buy
50,315
+65
+0.1% +$4.97K 0.95% 46
2017
Q2 		$3.56M Sell
50,250
-1,850
-4% -$123K 0.88% 47
2017
Q1 		$3.54M Buy
52,100
+655
+1% +$46.1K 0.88% 50
2016
Q4 		$3.68M Buy
+51,445
New +$3.82M 0.94% 48
2014
Q4 		– Sell
-60,771
Closed -$6.47M – 96
2014
Q3 		$6.47M Sell
60,771
-11,584
-16% -$1.13M 1.89% 10
2014
Q2 		$6M Buy
72,355
+690
+1% +$53.7K 1.81% 11
2014
Q1 		$5.08M Buy
71,665
+1,560
+2% +$122K 1.67% 18
2013
Q4 		$5.26M Buy
70,105
+1,260
+2% +$87.7K 1.75% 12
2013
Q3 		$4.33M Buy
68,845
+3,410
+5% +$204K 1.58% 15
2013
Q2 		$3.35M Buy
+65,435
New +$3.41M 1.33% 28

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oakwood Capital Management's GILD Position: Q4 2019 in Review

Oakwood Capital Management sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 47,673 shares — an estimated $3.02M sold.

Oakwood Capital Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $6.47M in Q3 2014. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Oakwood Capital Management reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Oakwood Capital Management sold 47,673 Gilead Sciences shares in Q4 2019, an estimated $3.02M.
  • Oakwood Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Oakwood Capital Management's Gilead Sciences position peaked at $6.47M in Q3 2014.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Oakwood Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.